|
Therapy for Addiction
Subtitle
Image*
[UPLOAD IMAGE HERE]
https://uc.technologypublisher.com/files/sites/screenshot_20221205_023818.png
Description*
UC researchers have developed a monoclonal antibody that recognizes and effectively binds cocaine. By administering this antibody, cocaine concentrations are much lower in the brain, which aid individuals battling drug...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Nils Lonberg, Denise Williams, W. James Ball, Andrew Norman
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Diseases & Disorders, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Life Sciences > Therapeutics > Protein Therapies, Technology Classifications > Life Sciences > Diseases & Disorders > Neurologic, Technology Classifications > Life Sciences
|
|
Glioma Treatment Utilizing Ep2 Antagonists (118014)
With 17,000 new cases diagnosed each year in the United States, malignant gliomas account for about 80% of all primary malignant brain tumors, with 82% of these cases classified as a grade IV tumor—glioblastoma multiforme (GBM). The median survival time of GBM patients from diagnosis with treatment is only about 15 months. Malignant gliomas are...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Jianxiong Jiang
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Diseases & Disorders > Cancer, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Life Sciences > Diseases & Disorders > Neurologic, Technology Classifications > Life Sciences > Therapeutics > Small Molecule, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Diseases & Disorders
|
|
R-2hg-Based Therapeutic Strategies Targeting Cancers (117-029)
According to the reports of the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program, in 2016 there were an estimated 414,773 people living with leukemia in the United States. Additionally, in 2016, there were an estimated 165,813 people living with brain and other nervous system cancer in the United States. With the...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Rui Su, Jianjun Chen
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Biomedical, Technology Classifications > Life Sciences > Diseases & Disorders > Cancer, Technology Classifications > Life Sciences > Diseases & Disorders > Neurologic, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Diseases & Disorders
|
|
Small Molecule Prolactin Receptor Inhibitors for Treatment of Cancers and Pain Disorders (117-018)
Each year, over a million women worldwide are diagnosed with breast cancer, accounting for 25% of all female cancers. About 1 in 8 women are predicted to develop this disease during her lifetime. Over the last two decades, single and combination chemotherapy, based on results from clinical trials, has led to a considerable reduction in morbidity and...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Armen Akopian, Abraham Domb, Edward Merino, Eric Hugo, Nira Ben-Jonathan
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Diseases & Disorders > Cancer, Technology Classifications > Life Sciences > Diseases & Disorders > Neurologic, Technology Classifications > Life Sciences > Therapeutics > Small Molecule, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Diseases & Disorders, Technology Classifications > Life Sciences > Therapeutics
|
|
New Therapeutic Leads for Cachexia and Anorexia (112-005)
Dr. Glenn Millhauser and his lab at the University of California, Santa Cruz (UCSC) in collaboration with Dr. Stephen Benoit at the University of Cincinnati have discovered a group of proteins that will ultimately be of value in treating extreme cases of eating disorders such as anorexia or cachexia.
The agouti-related protein (AgRP) is produced in...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Stephen Benoit
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Therapeutics > Protein Therapies, Technology Classifications > Life Sciences > Diseases & Disorders > Digestive, Technology Classifications > Life Sciences > Diseases & Disorders > Neurologic, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Diseases & Disorders, Technology Classifications > Life Sciences > Therapeutics
|